000 04169nam a22004095i 4500
999 _c9584
_d9584
001 9584
003 DE-He213
005 20210518040405.0
006 a||||fo|||| 00| 0
007 cr nn 008mamaa
008 171007s2018 gw | s |||| 0|eng d
020 _a9783319474977
024 7 _a10.1007/978-3-319-47497-7
_2doi
040 _aES-MaUEC
_bspa
_dES-VaUE
050 4 _aRC568
_b.M336 2018 EB
100 1 _aMcAnally, Heath B.
_eautor.
_4aut
_4http://id.loc.gov/vocabulary/relators/aut
_0http://id.loc.gov/authorities/names/no2018071041
_0http://viaf.org/viaf/5152820097200681375
245 1 0 _aOpioid Dependence:
_bA Clinical and Epidemiologic Approach
_cby Heath B. McAnally.
264 1 _aCham
_bSpringer International Publishing :
_bImprint: Springer
_c2018.
300 _a1 recurso en línea (XV, 301 páginas 22 ilustraciones, 16 ilustraciones a color)
336 _2rdacontent
_aTexto (visual)
_btxt
337 _2rdamedia
_aelectrónico
_bc
338 _2rdacarrier
_arecurso electrónico
_bcr
347 _atext file
_bPDF
490 0 _aMedicine (Springer-11650)
505 0 _aAn Epidemiologic Perspective -- Understanding the Agent, Part I: Opioid Biology and Basic Pharmacology -- Understanding the Agent, Part II: Adverse Effects -- Understanding the Agent, Part III: Specific Drugs -- Attenuating the Agent: Reducing Opioid “Virulence” -- Best Practices Education, Part I: Pain Physiology, Psychology, and Alternatives to Opioids -- Best Practices Education, Part II : Evidence for and against Opioid Therapy -- Best Practices Education, Part III: Regulatory and Advisory Issues Related to Opioid Therapy for Pain -- Addressing Host Factors: Overview of Dependence and Addiction -- Opioid Dependence Risk Factors and Risk Assessment -- Addressing Host Factors: Primary, Secondary and Tertiary Prevention of Opioid Dependence -- Conclusion.
520 3 _aThis unique and timely title offers a comprehensive assessment of the previously underappreciated risks and potentially overstated benefits of chronic opioid therapy. It does so by approaching the rampant problem of opioid abuse and addiction – currently labeled an epidemic in the United States -- from a public health/epidemiologic perspective. That is, following a thorough overview in Part 1 that compares (and contrasts) classic infectious disease epidemiology concepts with the epidemic, the book categorizes our current understanding of basic science and best clinical practices in opioid therapy in terms of Agent (opioid), Vector (prescriber) and Host (patient) factors. The majority of the book, which includes a plethora of instructional case studies, is organized according to these three arenas. Opioid Dependence: A Clinical and Epidemiologic Approach is designed to update all clinicians on opioid basic science, current areas of drug improvement research and development, alternatives to opioid therapy, evidence-based indications for opioid therapy, and clinical strategies for preventing and overcoming opioid dependence. Importantly, an overview of clinical practice guidelines from the American Society of Addiction Medicine, with its biopsychosocial-spiritual “multidimensional assessment” focus is provided, along with a discussion of medication-assisted treatment, organized by the three currently FDA-approved pharmacotherapeutics (methadone, buprenorphine and naltrexone). Developed for practitioners at every level, this ground-breaking title offers a fresh and novel approach to improving the care and outcomes of patients receiving opioid therapy.
650 7 _aPsiquiatría
_2embne
_9139041
650 7 _aNeurología.
_9139040
650 7 _aDolor.
_9137881
710 2 _aSpringerLink (Online service)
_0http://id.loc.gov/authorities/names/no2005046756
_0http://viaf.org/viaf/148105729
_9106996
776 0 8 _iEdición impresa:
_z9783319474960
776 0 8 _iEdición impresa:
_z9783319474984
776 0 8 _iEdición impresa:
_z9783319837512
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-319-47497-7
_zAcceso a este recurso digital (usuarios Universidad Europea de Valencia)
942 _2lcc
_cLE
998 _db